News
Dear SWTCRC members,
It is with a mixture of sadness and pride that we said farewell to the Sydney West TCRC yesterday on June 30, 2021. Our TCRC changed the world of oncology in the west of Sydney. Our MDTs have blossomed, matured, and continue to transform the way we care for our patients. The glistening new aspect of our MDTs is their role in recognising important clinical questions at the coal face, and presenting these to the research community to help solve. Watch for some exciting announcements in the next few months about how we will add further research firepower to our MDTs to enrich the environment in which we work, and improve outcomes.
It is with a mixture of sadness and pride that we said farewell to the Sydney West TCRC yesterday on June 30, 2021. Our TCRC changed the world of oncology in the west of Sydney. Our MDTs have blossomed, matured, and continue to transform the way we care for our patients. The glistening new aspect of our MDTs is their role in recognising important clinical questions at the coal face, and presenting these to the research community to help solve. Watch for some exciting announcements in the next few months about how we will add further research firepower to our MDTs to enrich the environment in which we work, and improve outcomes.
Professor Jacob George AM, SWTCRC Flagship Leader and Executive Committee member has been named as the 2021 recipient of the Sally Crossing Award which recognises outstanding achievement in cancer research, particularly research that includes consumer involvement. The HOTTeR West (Liver Wellness) Flagship program addresses the rising incidence of hepatocellular cancer (HCC) due to increasing prevalence of chronic viral hepatitis in Australia. The program aims to support patients and health professionals manage chronic disease that contributes to increased risk of HCC.
Dr Bateman observed that winning the SWTCRC ECR Accelerator grant is a big step forward saying, “Our collaboration unites research at The Children’s Hospital at Westmead and Westmead Institute for Medical Research. This enables innovative therapies to be translated for use on children by using knowledge gained from research based on adults.”
As part of Ovarian Cancer Awareness month, VIVA! communications spoke with SWTCRC co-Deputy Director Professor Anna DeFazio about the projects in ovarian cancer she and her team are currently involved in and why keeping ovarian cancer at the forefront of national attention is critical to improving outcomes for women diagnosed with the disease.
Congratulations to A/Prof Alison Brand who was awarded Member, Order of Australia (AM) in the Australia Day Honours for services to Gynaecology, Medicine, and Medical organisations.
SWTCRC co-Deputy Director Professor Anna DeFazio has been recognised for Outstanding Mentoring and Leadership in the 2020 University of Sydney Vice Chancellor's Awards. Now in its fifth year, the awards celebrate the outstanding contributions of our academic and professional staff to teaching, research and service, leadership, mentorship, and industry and community engagement.
Dr Ali Azimi, Dr Caroline Bateman and Dr David Bishop have been awarded ECR Accelerator Grants from SWTCRC.
SWTCRC co-Deputy Director, Professor Anna DeFazio, has been awarded the Jeannie Ferris Cancer Australia Recognition Award in recognition of her outstanding contributions to ovarian cancer research. Professor DeFazio is one of Australia’s leading translational ovarian cancer researchers.
SWTCRC Executive member and Flagship leader, Professor Jacob George, has been awarded the Okuda-Omata Award, only the second time this award has been conferred. The award recognises scientific contributions of outstanding significance in the field of hepatology (the study of liver diseases).
'A great honour': Jacob George awarded for lifetime of work in liver health.
'A great honour': Jacob George awarded for lifetime of work in liver health.
Nguyen H, Butow P, Dhillon H, Morris L, Brown A, West K, Sundaresan P. (2020). Using patient‐reported outcomes (PROs) and patient‐reported outcome measures (PROMs) in routine head and neck cancer care: What do health professionals perceive as barriers and facilitators? J Med Imaging Radiat Oncol. doi:10.1111/1754-9485.13048